7140 Federal Register / Vol. 90, No. 12 / Tuesday, January 21, 2025 / Notices 

existing information collection 

requirements associated with the Rule, 

which the Commission has undertaken 

for years and seeks to continue. It did 

not concern a proposed rulemaking. 

Pursuant to the OMB regulations, 5 CFR 

part 1320, that implement the PRA, 44 

U.S.C. 3501 et seq., the FTC is providing 

this second opportunity for public 

comment while seeking OMB approval 

to renew the pre-existing clearance for 

the Rules. 

Your comment—including your name 

and your state—will be placed on the 

public record of this proceeding. 

Because your comment will be made 

public, you are solely responsible for 

making sure that your comment does 

not include any sensitive personal 

information, such as anyone’s Social 

Security number; date of birth; driver’s 

license number or other state 

identification number, or foreign 

country equivalent; passport number; 

financial account number; or credit or 

debit card number. You are also solely 

responsible for making sure that your 

comment does not include any sensitive 

health information, such as medical 

records or other individually 

identifiable health information. In 

addition, your comment should not 

include any ‘‘trade secret or any 

commercial or financial information 

which . . . is privileged or 

confidential’’—as provided by Section 

6(f) of the FTC Act, 15 U.S.C. 46(f), and 

FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— 

including in particular competitively 

sensitive information such as costs, 

sales statistics, inventories, formulas, 

patterns, devices, manufacturing 

processes, or customer names. 

Josephine Liu, 

Assistant General Counsel for Legal Counsel. 

[FR Doc. 2025–01302 Filed 1–17–25; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Advisory Board on 

Radiation and Worker Health, National 

Institute for Occupational Safety and 

Health 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting of the Advisory 

Board on Radiation and Worker Health 

(ABRWH or the Advisory Board). This 

meeting is open to the public, but 

without a public comment period. The 

public is welcome to submit written 

comments in advance of the meeting, to 

the contact person listed in the 

Addresses section below. Written 

comments received in advance of the 

meeting will be included in the official 

record of the meeting. The public is also 

welcome to listen to the meeting by 

joining the teleconference (information 

below), limited only by the number of 

audio conference lines available (150). 

DATES: The meeting will be held on 

February 25, 2025, from 11 a.m. to 1 

p.m., EST. Written comments must be 

received on or before February 18, 2025. 

ADDRESSES: You may submit comments 

by mail to: Dr. Rashaun Roberts, 

National Institute for Occupational 

Safety and Health (NIOSH), 1090 

Tusculum Avenue, Mailstop C–24, 

Cincinnati, Ohio 45226. 

Meeting Information: Audio 

Conference Call via FTS Conferencing. 

The USA toll-free dial-in number is 1– 

866–659–0537; the passcode is 9933701. 

FOR FURTHER INFORMATION CONTACT: 

Rashaun Roberts, Ph.D., Designated 

Federal Officer, National Institute for 

Occupational Safety and Health, Centers 

for Disease Control and Prevention, 

1090 Tusculum Avenue, Mailstop C–24, 

Cincinnati, Ohio 45226. Telephone: 

(513) 533–6800; Toll Free 1(800) 232– 

4636; Email: ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines, 

which have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule; advice on 

methods of dose reconstruction which 

have also been promulgated by HHS as 

a final rule; advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program, and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). In 

December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, 

which subsequently delegated this 

authority to the CDC. NIOSH 

implements this responsibility for CDC. 

The charter was issued on August 3, 

2001, renewed at appropriate intervals, 

and rechartered under Executive Order 

13179 on March 22, 2024. Unless 

continued by the President, the Board 

will terminate on September 30, 2025, 

consistent with E.O. 14109 of September 

29, 2023. 

Purpose: The Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advising the Secretary 

on whether there is a class of employees 

at any Department of Energy (DOE) 

facility who were exposed to radiation 

but for whom it is not feasible to 

estimate their radiation dose, and on 

whether there is reasonable likelihood 

that such radiation doses may have 

endangered the health of members of 

this class. 

Matters to be Considered: The agenda 

will include discussions on the 

following: Update on the Cybersecurity 

Modernization Initiative; workgroup 

and subcommittee reports; update on 

the status of SEC petitions; and plans for 

the April 2025 Advisory Board meeting. 

Agenda items are subject to change as 

priorities dictate. For additional 

information, please contact Toll Free 1– 

800–232–4636. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2025–01318 Filed 1–17–25; 8:45 am] 

BILLING CODE 4163–18–P 


ddrumheller on DSK120RN23PROD with NOTICES1